Risk factor
Strong trading liquidity
Profitability factor
Favourable price performance
About
Shanghai Haoyuan Chemexpress Co., Ltd. is dedicated to the innovation and advancement of key compounds for the pharmaceutical industry, focusing on small molecule drugs and their essential intermediates. The company's production capabilities encompass active pharmaceutical ingredients (APIs) and their precursors, various vitamin D series substances, as well as specialized chemical building blocks and life science compounds tailored for contract research organizations (CROs). Established in 2006, its primary operational base is located in Shanghai, China.
Company Valuation
Based on key historical and expected multiples, the stock is greatly overvalued relative to its peers. Specifically, the stock is 'expensive' on P/E, overvalued on EV/EBI